Introduction {#sec1}
============

*Helicobacter pylori* (HP) is a common infectious factor all over the world. It is known that this infection increases with low socioeconomic level and family structure. HP infection is seen more frequently and earlier in developing countries compared to developed countries. Mostly, HP is associated with gastrointestinal infection, and is one of the major aetiological causes of gastric malignancies, mucosa-related lymphoma, peptic ulcer, and chronic gastritis \[[@cit0001]\].

Thrombocytes are specialised blood cells playing primary roles in haemostasis, thrombosis, and coagulation. This may be examined during automatic whole blood count without incurring any extra costs. The mean platelet volume (MPV) is an indicator of the platelet function and activation and is measured with clinical haematology analysis \[[@cit0002]\]. Thrombocyte volume measurements are objective measurements in evaluating the thrombocyte size. Increasing MPV is associated with an increase in the megakaryocytic growth in response to the thrombopoietic stress response \[[@cit0003]\]. If there is inflammation in the body, some cytokines and chemokines are released from the thrombocyte membranes \[[@cit0004], [@cit0005]\]. In this way, during the inflammation, platelet activation may be measured indirectly with MPV. The measurement of MPV is easy and cheap. It was shown in previous studies that MPV is a useful method in evaluating thrombocyte function and activation \[[@cit0006]\]. Inflammation is an important stimulus for thrombocytes. MPV was examined in many diseases as a simple inflammatory marker. Thrombocyte volume and structural changes might help in the differential and early diagnosis of several diseases. Several studies examined the relation between MPV and some diseases \[[@cit0007]--[@cit0013]\].

Aim {#sec2}
===

In this study, it was examined whether there is a relation between the presence of HP and gastritis, MPV, and platelet count.

Material and methods {#sec3}
====================

A total of 309 patients who applied to the Healthcare Sciences University, Van Education Hospital, Paediatric Gastroenterology Polyclinic between October 2017 and October 2018, who had dyspeptic complaints and who received upper gastrointestinal system endoscopy and gastric biopsy were included in the present cross-sectional study. Those who had systemic diseases or received treatment for systemic diseases, those who used drugs that affected thrombocyte functions, those who had another inflammatory or infectious disease, thyroid disease, malignity, renal, cardiac, and liver failures, diabetes mellitus, hypertension, inflammatory bowel disease, and those who had haematological diseases were excluded from the study. Biochemical measurements and biochemical parameters were measured from the antecubital venous blood samples that were taken in the morning hours after eight hours of fasting. MPV measurements were made within 30 min after the blood samples were taken. The samples were collected with tubes that included dipotassium EDTA. In the present study, the complete blood count analysis was made with an automatic haematology analyser: Beckman Coulter LH 750 (Beckman Coulter, USA). Thrombocyte and MPV levels were also measured. Age, gender, MPV, thrombocytes, the presence and intensity of HP, and the presence of histopathological gastritis and its severity were investigated. Gastritis was classified according to the Modified Sydney System \[[@cit0014]\]. The presence of HP was recorded as 1 (+), 2 (+), or 3 (+), and the presence of gastritis was interpreted as no gastritis, mild, moderate, and severe gastritis. The MPV and thrombocyte values were compared in patients who were HP positive and HP negative and who did not have gastritis.

Statistical analysis {#sec3.1}
--------------------

Normal distribution was tested by using the Shapiro-Wilk test. Mann-Whitney *U* test was used to compare non-normal variables between two independent groups. Spearman's rank correlation coefficient was used to test the relationships between numerical variables. ROC curve analysis was performed to determine the diagnostic accuracy of numeric variables. Mean ± standard deviation for numeric variables and frequency and percentages for categorical variables were given as descriptive statistics. SPSS 24.0 software package was used in the analyses. *P* \< 0.05 was accepted as being statistically significant.

Results {#sec4}
=======

A total of 35% (*n* = 109) of the patients were male and 65% (*n* = 200) were female. The average age of the cases included in the present study was 12 ±6 years. A total of 36% of the cases were HP(--) and 64% were HP(+) . A total of 29% of the HP positive cases were 1 (+), 24% were 2 (+), and 11% were 3 (+). No gastritis was detected in 22% of the cases. Mild gastritis was detected in 38%, moderate gastritis was detected in 30%, and severe gastritis was detected in 10% of the cases ([Table I](#t0001){ref-type="table"}). No significant differences were detected in terms of MPV values between HP(+) and HP(--). The platelet values were detected to be low in the HP(+) group at a significant level (*p* = 0.038). ROC curve analysis was carried out to determine the diagnostic value of the platelets in differentiation between the HP(+) and HP(--) groups. The AUC value was measured to be 0.572. This value shows that platelets have a weak distinguishing characteristic. In the ROC analysis, the specificity was determined to be 65% (95% CL: 55.4--74), and the sensitivity was determined to be 49.5% (95% CL: 42.4--56.6). The MPV measurements were made between HP(+) and HP(--) subgroups, and a statistically significant difference was detected between the HP(2+) and HP(--) groups (*p* = 0.022). The MPV values were high in the HP(2+) group at a significant level. Again, the same relation was observed for platelet level (*p* = 0.017). A statistically significant relation was determined between the platelet and MPV values in all groups. This result means that as the MPV value increases, the platelet value decreases. The ROC curve analysis was performed for the purpose of evaluating the diagnostic value of MPV in distinguishing between the HP(2+) and HP(--) groups. The sensitivity was determined to be 87% (AUC = 0.600 ±0.042, *p* = 0.0175), and the specificity was determined to be 31.8%. In the ROC curve analysis that was made for platelet levels, the specificity was determined to be 65% and the sensitivity was determined to be 56.7% ([Table II](#t0002){ref-type="table"}).

###### 

*Helicobacter pylori*, gastritis, and gender frequency in the cases receiving endoscopy

  Variables      *N*   \%
  -------------- ----- ----
  *H. pylori:*         
   Negative      110   36
   1(+)          91    29
   2(+)          74    24
   3(+)          34    11
  Gender:              
   Male          109   35
   Female        200   65
  Gastritis:           
   Negative      67    22
   Mild          117   38
   Moderate      93    30
   Severe        32    10

###### 

Comparison of the MPV and platelet values between the HP-negative and HP-positive cases

  Parameter   HP(+)            HP(--)          *P*\*   HP(+)           *P*\*\*   HP(2+)          *P*\*\*\*   HP(3+)          *P*\*\*\*\*
  ----------- ---------------- --------------- ------- --------------- --------- --------------- ----------- --------------- -------------
  MPV         9.31 ±1.06       9.09 ±1.24      0.281   9.15 ±1.12      0.647     9.53 ±0.98      0.022       9.2 ±0.87       0.882
  Platelet    325251 ±263617   332596 ±93237   0.038   314197 ±77522   0.309     349121 ±42315   0.017       303823 ±66763   0.193

P\* -- The p-value between the HP-positive and HP-negative cases, P\*\* -- the p-value between the HP(1+) and HP(--) cases, P\*\*\* -- the p-value between the HP(2+) and HP(--) cases, P\*\*\*\* -- the p-value between the HP(3+) and HP(--) cases.

Although no significant differences were detected in terms of MPV in all patients who had and who did not have gastritis, a significant difference was detected in terms of platelet count between the groups (*p* = 0.049). In the ROC curve analysis that was made to evaluate the diagnostic value of platelet levels in the gastritis (--) and gastritis (+) groups, the specificity was determined to be 74%, the sensitivity was determined to be 42.5%, and a weak relation was detected. In the comparison that was made between the non-gastritis patients and the subgroups that had various severity levels, a difference was observed between the gastritis (--) and moderate-severe gastritis groups only in terms of platelet values (*p* = 0.038). When the diagnostic distinctiveness of this test was analysed (AUC = 0.596 ±0.045, *p* = 0.032), it was interpreted as a poorly distinguishing characteristic ([Table III](#t0003){ref-type="table"}).

###### 

Comparison of MPV and platelet values between the gastritis-negative and gastritis-positive cases

  Parameter   Gastritis negative (*n* = 67)   Gastritis positive (*n* = 242)   *P*\*   Gastritis (mild) (*n* = 117)   *P*\*\*   Gastritis (moderate) (*n* = 93)   *P*\*\*\*   Gastritis (severe) (*n* = 32)   *P*\*\*\*\*
  ----------- ------------------------------- -------------------------------- ------- ------------------------------ --------- --------------------------------- ----------- ------------------------------- -------------
  MPV         9.06 ±1.03                      9.28 ±1.15                       0.125   9.19 ±1.29                     0.373     9.39 ±1.02                        0.057       9.28 ±0.97                      0.323
  Platelet    335238 ±92246                   325794 ±242786                   0.049   317164 ±80773                  0.033     306924 ±85566                     0.038       412187 ±634865                  0.252

P\* -- the p-value between the gastritis-positive and gastritis-negative cases, P\*\* -- the p-value between the gastritis (mild) and gastritis-negative cases, P\*\*\* -- the p-value between the gastritis (moderate) and gastritis-negative cases, P\*\*\*\* -- the p-value between the gastritis (severe) and gastritis-negative cases.

Discussion {#sec5}
==========

Platelets play active roles in haemostasis and in the regulation of inflammatory processes \[[@cit0009]\]. In recent years, numerous studies have been conducted on the clinical significance of MPV. An increase in MPV is accepted as a marker of inflammation; it is also related to platelet activation \[[@cit0015], [@cit0016]\]. There are controversial results about MPV and inflammatory diseases in the literature. Although the MPV value increases in some inflammatory diseases, it decreases in others, and although MPV increases in tissue oxygenation and malnutrition \[[@cit0011]--[@cit0013], [@cit0017], [@cit0018]\], it was reported that MPV is low in inflammatory bowel diseases, pneumonia, and in the acute stage of familial Mediterranean fever \[[@cit0019]--[@cit0022]\]. In addition, it was also reported that MPV is increased at a significant level in other inflammatory diseases like rheumatoid arthritis, ankylosing spondylitis, and Behcet's disease and in the active stages of these diseases \[[@cit0017], [@cit0023], [@cit0024]\]. In the present study, it was determined that the platelet count was low in patients who had HP positivity. In the ROC curve analysis, we determined a poor relation between the HP positivity and platelet levels, with a sensitivity of 49% and a specificity of 65%. We did not determine any relations between *H. pylori* positivity and MPV. The patients who had moderate level HP(+2) positivity had high MPV values. A weak relation was detected in the ROC curve analysis in this respect. As it was shown by Aktas *et al*. article conducted on gastrointestinal system, MPV was reported as high in patients who had irritable bowel syndrome \[[@cit0025]\], and MPV was low in patients who had inflammatory bowel diseases, rotavirus gastroenteritis, cystic fibrosis, acute pancreatitis, and acute hepatitis A infection \[[@cit0007]--[@cit0010]\]. Topal *et al.* and Yeniova *et al.* determined that there are no relations between HP, platelet levels, and MPV \[[@cit0026], [@cit0027]\]. In a study conducted by Umit *et al.* higher MPV levels in HP-positive patients was reported \[[@cit0028]\]. Ugras *et al.* conducted a study and reported that HP did not affect MPV; however, MPV values were lower in patients who had HP-related gastritis compared to the participants in the control group \[[@cit0029]\]. Although there are very few studies conducted in this field, different results were reported in different studies. In the present study of ours, no relations were detected between gastritis severity and the presence of gastritis and MPV. The platelet values were lower in patients who had gastritis. We detected a poor relation in the ROC curve analysis of the patients who did not have gastritis and those who had mild and moderate-severe gastritis, in terms of platelet levels. In a study by Topal *et al.*, they reported lower MPV levels in patients who had moderate and severe gastritis \[[@cit0026]\]. Ugras *et al.*, on the other hand, detected no relation between gastritis and MPV, which is similar to our study \[[@cit0029]\].

Conclusions {#sec6}
===========

As a result, a weak relation was detected between the MPV and platelet values in patients who applied with dyspeptic complaints. Although no relation was detected between the presence or severity of gastritis and MPV, unlike other inflammatory and infectious diseases, which was also reported in previous studies, a poor relation was detected between the presence of gastritis and platelet values.
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